Your browser doesn't support javascript.
Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms.
Ramprasath, Tharmarajan; Natarajan, Nandakumar; Gopas, Jacob; Subbiah, Ramasamy; Rajendran, Peramaiyan; Vaiyapuri, Sakthivel.
  • Ramprasath T; Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA, United States.
  • Natarajan N; The University of Texas Health Science Center at Tyler, Tyler, TX, United States.
  • Gopas J; Ben-Gurion University of the Negev, Beersheba, Israel.
  • Subbiah R; Department of Biochemistry, School of Biological Sciences, Madurai Kamaraj University Madurai, Madurai, India.
  • Rajendran P; Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
  • Vaiyapuri S; University of Reading, Reading, United Kingdom.
Front Pharmacol ; 13: 1088908, 2022.
Article in English | MEDLINE | ID: covidwho-2244495
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.1088908

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.1088908